盆腔器官运动对宫颈癌IMRT靶区剂量的影响
本研究回顾性分析10例宫颈癌放化疗患者的105次CBCT图像,评估器官充盈导致原发CTV位置变化对剂量的影响。结果显示部分分次出现CTV低剂量,计划膀胱体积>300cc者变异最大,重新计划可改善覆盖。建议计划时膀胱体积150-300cc,治疗时保持在计划体积-50cc至+150cc范围内。
要点
- 计划膀胱体积>300cc者CTV剂量变异最大,重新计划可改善覆盖。
- 膀胱体积在计划体积-50cc至+150cc时,93%分次D99>95%。
- 前中子宫点覆盖最差,中位剂量98.7%,大膀胱体积时降至91.4%。
核心结论
- 器官位置变化对原发CTV(包括宫颈)的剂量有不利影响。
- 计划膀胱体积>300cc导致更大变异,重新计划可改善覆盖。
- 建议计划时膀胱体积150-300cc,治疗时保持在计划体积-50cc至+150cc。
研究设计与样本
- 回顾性分析10例接受宫颈癌放化疗患者的每周两次CBCT图像,共105次扫描。
- 勾画原发CTV、膀胱和直肠,使用10-15mm CTV-PTV margin创建RapidArc计划。
- 采用新型向量方法计算基于每次CBCT位置的CTV剂量,并分析中央子宫、中子宫和宫颈向量及特定点的剂量。
- 对计划膀胱体积大的病例,使用膀胱体积150-300cc时的CTV创建额外RapidArc计划。
主要发现
- 向量分析显示部分病例CTV低剂量:2例所有三个向量平均覆盖低于95%,1例一个向量低于95%。
- 体积分析显示48%的分次D99<95%。
- 计划膀胱体积>300cc的患者变异最大,重新计划改善了覆盖。
- 前中子宫点覆盖最差,中位剂量98.7%,计划膀胱体积大时降至91.4%,重新计划显著改善。
- 膀胱体积在计划体积-50cc至+150cc时,93%分次D99>95%,而超出此范围时仅24%;D95>95%分别为100%和84%。
关键数值与推荐
- 计划膀胱体积>300cc与更大变异相关。
- 膀胱体积在计划体积-50cc至+150cc时,93%分次D99>95%,24%分次在范围外。
- D95>95%在范围内为100%,范围外为84%。
- 前中子宫点中位剂量98.7%,大膀胱体积时91.4%。
临床怎么用
- 计划时膀胱体积建议150-300cc。
- 治疗时膀胱体积保持在计划体积-50cc至+150cc范围内。
- 对计划膀胱体积大的患者考虑重新计划以改善CTV覆盖。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Advanced radiotherapy techniques reduce normal tissue dose by conforming closely to target volumes. In cervical cancer radiotherapy, organ filling affects clinical target volume (CTV; cervix, uterus) position. This study estimates the dosimetric effect of this primary CTV position variation during chemoradiation. METHODS/MATERIALS: Twice weekly cone-beam computed tomography (CBCT) images of ten patients undergoing cervical chemoradiation were retrospectively analysed. Primary CTV, bladder and rectum were delineated. RapidArc plans were created using 10-15mm CTV-PTV margins and dose delivered to CTV based on each CBCT position was calculated using a novel vector approach. Dose delivered along the central uterine, mid-uterus and cervix vectors were analysed as well as dose delivered to points at uterine tip, anterior mid-uterus and anterior cervix. Additional RapidArc plans were created for large planning bladder volume cases using the CTV acquired with bladder volume at 150-300cc. RESULTS: 105 scans for 10 patients were analysed. Vector analysis revealed CTV underdosing in certain cases. Below 95% average vector coverage was found for all three vectors in 2 cases and one vector in 1 case. Volumetric analysis revealed D99<95% in 48% of fractions. Patients with large planning bladder volumes (>300cc) demonstrated the largest variation. Replanning improved this coverage. The anterior mid-uterus point was least well-covered; median 98.7% dose, reducing to 91.4% in cases with large planning bladder volumes. Again, replanning significantly improved this. D99>95% was maintained in 93% of fractions when bladder volume was 50cc below to 150cc above planning volume compared to 24% of fractions if bladder volume was outside this range. Similarly, D95>95% was 100% versus 84%. CONCLUSION: Organ position variation detrimentally affected dose delivered to CTV including cervix. Large planning bladder volumes (>300cc) led to more variation. We recommend bladder volumes of 150-300cc at planning and a range of 50cc below to 150cc above planning for treatment.
引用
- Eminowicz G, Rompokos V, Stacey C, et al. Understanding the impact of pelvic organ motion on dose delivered to target volumes during IMRT for cervical cancer. Radiother Oncol. 2016. PMID: 27863962. doi:10.1016/j.radonc.2016.10.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。